China Microarray Market Size, Share, Forecast, & Trend Analysis by Product (Consumables [Microarray Kits {DNA (cDNA, Oligo), Protein}], Instruments, Software, Services), Application (Drug Discovery, Research, Diagnostics), End User— Forecast to 2031

China Microarray Market Size, Share, Forecast, & Trend Analysis by Product (Consumables [Microarray Kits {DNA (cDNA, Oligo), Protein}], Instruments, Software, Services), Application (Drug Discovery, Research, Diagnostics), End User— Forecast to 2031


China Microarray Market Size, Share, Forecast, & Trend Analysis by Product (Consumables [Microarray Kits {DNA (cDNA, Oligo), Protein}], Instruments, Software, Services), Application (Drug Discovery, Research, Diagnostics), End User—Forecast to 2031

The China microarray market is projected to reach $910.4 million by 2031, at a CAGR of 8.4% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by increasing research applications of the microarray technology, growth in genomics & proteomics research, rising prevalence of cancers & genetic disorders, and growing R&D expenditures in the pharmaceutical & biotechnology industries.

Additionally, advancements in microarray technology and the growing adoption of personalized medicines provide significant growth opportunities for this market. However, the elevated costs of microarray compared to other genetic testing methods may restrain the growth of this market. Furthermore, the lack of sensitivity and accuracy in microarray poses a major challenge for the players operating in this market.

Among the products studied in this report, in 2024, the consumables segment is expected to account for the largest share of the China microarray market. Consumables encompass kits and additional items necessary for microarray applications, ensuring comprehensive and optimal sample preparation for accurate results and analysis. The large market share is driven by factors including streamlined workflows, reduced errors, cost efficiency, and minimized waste.

Among the applications studied in this report, in 2024, the drug discovery & development segment is expected to account for the largest share of the China microarray market. This large market share is attributed to factors such as elevated pharmaceutical R&D expenditures, a growing demand for novel drugs, increased government funding for drug discovery and development, and the rising adoption of microarray technology for identifying suitable therapeutic targets.

Among the end users studied in this report, in 2024, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the China microarray market. This large market share is driven by factors such as rising healthcare expenditures, increased investment and funding in pharmaceutical companies, advancements in research and development, and enhanced patient outcomes.

Some of the major players studied in this report are Sino Biological, Inc. (China), CapitalBio Technology Co., Ltd. (China), Arrayit Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), and Qiagen N.V. (Netherlands), and RayBiotech Life, Inc. (U.S.).

Scope of the Report:

China Microarray Market Assessment—by Product

Consumables
Kits
DNA & RNA Microarray Kits
cDNA Microarray Kits
Oligo Microarray Kits

Other DNA & RNA Microarray Kits

(Other DNA & RNA microarray kits comprise RNA microarray, SNP microarray, and BAC microarray)
Protein Microarray Kits
Tissue Microarray Kits

Other Microarray Kits

(Other microarray kits comprise cell microarray, ChIP-chip microarray (Chromatin Immunoprecipitation Microarray), and glycan microarray)

Other Consumables

(Other consumables comprise buffers, reagents, slides, well plates, coated slides, and microtiter plates)
Instruments
Software
Services

China Microarray Market Assessment—by Application

Drug Discovery & Development
Research Applications
Diagnostics

Other Applications

(Other applications comprise agriculture, food & beverage, and forensics)

China Microarray Market Assessment—by End User

Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Research & Academic Institutes
Hospitals & Diagnostic Laboratories

Other End Users

(Other end users comprise veterinary clinics, agricultural industry, and forensic laboratories)


1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Size and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for The Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Macro Indicators
4.3. Key Trends
4.3.1. Use of Microarrays in Forensics
4.3.2. Growing Use of 3D-printed Microarrays
4.4. Regulatory Analysis
4.5. Pricing Analysis
4.6. PESTLE Analysis
4.6.1. Political Factors
4.6.2. Economic Factors
4.6.3. Social Factors
4.6.4. Technological Factors
4.6.5. Legal Factors
4.6.6. Environmental Factors
4.7. Parent/Adjacent Market Analysis
4.7.1. IVD Industry Landscape
5. China Microarray Market Assessment—By Product
5.1. Overview
5.2. Consumables
5.2.1. Kits
5.2.1.1. DNA & RNA Microarray Kits
5.2.1.1.1. Oligo Microarray Kits
5.2.1.1.2. cDNA Microarray Kits
5.2.1.1.3. Other DNA & RNA Microarray Kits
5.2.1.2. Protein Microarray Kits
5.2.1.3. Tissue Microarray Kits
5.2.1.4. Other Microarray Kits
5.2.2. Other Consumables
5.3. Instruments
5.4. Software
5.5. Services
6. China Microarray Market—By Application
6.1. Overview
6.2. Drug Discovery & Development
6.3. Diagnostics
6.4. Research Applications
6.5. Other Applications
7. China Microarray Market—By End User
7.1. Overview
7.2. Pharmaceutical and Biotechnology Companies
7.3. Contract Research Organizations (CROs)
7.4. Academic & Research Institutes
7.5. Hospitals & Diagnostic Laboratories
7.6. Other End Users
8. Competition Analysis
8.1. Overview
8.2. Key Growth Strategies
8.3. Competitive Benchmarking
8.4. Competitive Dashboard
8.4.1. Industry Leaders
8.4.2. Market Differentiators
8.4.3. Vanguards
8.4.4. Emerging Companies
8.5. Market Share Analysis (2023)
8.5.1. Thermo Fisher Scientific Inc. (U.S.)
8.5.2. Illumina, Inc. (U.S.)
8.5.3. Merck KGaA (Germany)
8.5.4. Revvity, Inc. (Formerly Known As PerkinElmer, Inc.) (U.S.)
8.5.5. Agilent Technologies, Inc. (U.S.)
9. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
9.1. Thermo Fisher Scientific, Inc.
9.2. Illumina, Inc.
9.3. Merck KGaA
9.4. Revvity, Inc.
9.5. Agilent Technologies, Inc.
9.6. QIAGEN N.V.
9.7. Sino Biological, Inc.
9.8. Capitalbio Technology Co., Ltd.
9.9. Arrayit Corporation
9.10. Raybiotech Life, Inc.
(SWOT analysis is provided for top 5 players)
Table 1 China: Number of New Cancer Cases, by Type, 2022 Vs. 2045
Table 2 China: List of Personalized Medicine (PM)-related Policy Measures
Table 3 China: Major Genome Sequencing Projects
Table 4 China: Availability of Physicians and Nurses, 2022
Table 5 Microarray Instruments and Consumables: Average Selling Prices
Table 6 China Microarray Market, by Product, 2022-2031 (USD Million)
Table 7 China Microarray Consumables Market, by Type, 2022-2031 (USD Million)
Table 8 China Microarray Kits Market, by Type, 2022-2031 (USD Million)
Table 9 China DNA & RNA Microarray Kits Market, by Type, 2022-2031 (USD Million)
Table 10 China Microarray Market, by Application, 2022-2031 (USD Million)
Table 11 China Microarray Market, by End User, 2022-2031 (USD Million)
Table 12 Contract Research Organizations Operating in China
Table 13 Recent Developments, by Company, 2021–2024
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 China Microarray Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 8 China Microarray Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 9 China Microarray Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 10 Impact Analysis of Market Dynamics
Figure 11 China: Pharmaceutical R&D Expenditure, 2010 Vs. 2020 Vs. 2021 (USD Million)
Figure 12 Global Biopharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 13 China: Medical Device Classification and Premarket Requirements for IVD Products
Figure 14 China Microarray Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 15 China Oligo Microarray Kits Market, 2022-2031 (USD Million)
Figure 16 Glass CDNA Manufacturing Process
Figure 17 China CDNA Microarray Kits Market, 2022-2031 (USD Million)
Figure 18 China Other DNA & RNA Microarray Kits Market, 2022-2031 (USD Million)
Figure 19 China Protein Microarray Kits Market, 2022-2031 (USD Million)
Figure 20 China Tissue Microarray Kits Market, 2022-2031 (USD Million)
Figure 21 China Other Microarray Kits Market, 2022-2031 (USD Million)
Figure 22 China Other Consumables Market, 2022-2031 (USD Million)
Figure 23 China Microarray Instruments Market, 2022-2031 (USD Million)
Figure 24 China Microarray Software Market, 2022-2031 (USD Million)
Figure 25 China Microarray Services Market, 2022-2031 (USD Million)
Figure 26 China Microarray Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 27 China Microarray Market for Drug Discovery & Development, 2022-2031 (USD Million)
Figure 28 China Microarray Market for Diagnostics, 2022-2031 (USD Million)
Figure 29 China Microarray Market for Research Applications, 2022-2031 (USD Million)
Figure 30 China Microarray Market for Other Applications, 2022-2031 (USD Million)
Figure 31 China Microarray Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 32 China Microarray Market for Pharmaceutical and Biotechnology Companies, 2022-2031 (USD Million)
Figure 33 China Microarray Market for Contract Research Organizations, 2022-2031 (USD Million)
Figure 34 China Microarray Market for Academic & Research Institutes, 2022-2031 (USD Million)
Figure 35 China Microarray Market for Hospitals & Diagnostic Laboratories, 2022-2031 (USD Million)
Figure 36 China Microarray Market for Other End Users, 2022-2031 (USD Million)
Figure 37 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 38 China Microarray Market: Competitive Benchmarking by Product
Figure 39 Competitive Dashboard: China Microarray Market
Figure 40 China: Microarray Market Share Analysis, by Key Players (2023)
Figure 41 Thermo Fisher Scientific, Inc.: Financial Overview (2023)
Figure 42 Illumina, Inc.: Financial Overview (2023)
Figure 43 Merck KGaA: Financial Overview (2023)
Figure 44 Revvity, Inc.: Financial Overview (2023)
Figure 45 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 46 Qiagen N.V.: Financial Overview (2023)
Figure 47 Sino Biological, Inc.: Financial Overview (2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings